Floatz logo

Therapeutic Asset Ratings

204 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
cd70-targeting car-t cells
Lung Cancer
Chongqing Precision Biotech Co., LtdP1C (37)
Cid-078 Monotherapy
Lung Cancer
Circle PharmaP1C (37)
Clsp-1025
Lung Cancer
Clasp Therapeutics, Inc.P1C (37)
Cpg-Odn
Lung Cancer
Second Affiliated Hospital of Guangzhou Medical UniversityP1C (37)
do-2
Lung Cancer
DeuterOncologyP1C (37)
Dp Cd8 Til
Lung Cancer
AgonOx, Inc.P1C (37)
gc203 til
Lung Cancer
Shanghai Juncell TherapeuticsP1C (37)
Guadecitabine
Lung Cancer
Memorial Sloan Kettering Cancer CenterP1C (37)
Hbi-2438
Lung Cancer
HUYABIO International, LLC.P1C (37)
hs-10504
Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (37)
hs-20117
Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (37)
hs-20122
Lung Cancer
Hansoh BioMedical R&D CompanyP1C (37)
HUMAN FAECAL MATTER
Lung Cancer
M.D. Anderson Cancer CenterP1C (37)
Idov-Immune
Lung Cancer
ViroMissile, Inc.P1C (37)
Kk-Lc-1 Tcr-T Cells
Lung Cancer
Christian HinrichsP1C (37)
Loperamide
Lung Cancer
M.D. Anderson Cancer CenterP1C (37)
Lutetium [177Lu] Bl-Arc001
Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P1C (37)
MNPR-101-DFO-89Zr
Lung Cancer
Monopar TherapeuticsP1C (37)
Mnpr-101-Pcta-177Lu
Lung Cancer
Monopar TherapeuticsP1C (37)
QXL138AM
Lung Cancer
Nammi Therapeutics IncP1C (37)
RSC-1255
Lung Cancer
RasCal Therapeutics, Inc.P1C (37)
Sarilumab
Lung Cancer
M.D. Anderson Cancer CenterP1C (37)
Shr-1826
Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (37)
Shr-A2009
Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (37)
Shr-A2102
Lung Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1C (37)
Showing 151 to 175 of 204 assets
PreviousPage 7 of 9Next